Aging baby boomers spell good news for the $11 billion total joint replacement industry. The bad news is the economic burden this highly active population, the major recipients of joint replacement surgeries, will place on the nation's health care system. With the number of TJR procedures expected to soar in the coming years, it's no surprise that CMS is focused on reducing the costs of TJR procedures. And that's bad news for the orthopedic surgeons who perform them.
by Sharon O’Reilly
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
